BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

  January 8, 2026

   · 

  5 min read
• Press Releases

  BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease

  January 8, 2026

   · 

  5 min read
• Press Releases

  Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award

  January 8, 2026

   · 

  4 min read
• Press Releases

  Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

  January 8, 2026

   · 

  4 min read
• Press Releases

  Distinguished Neuroscience Expert Magali Haas, MD/PhD, Joins Psilera as Chief Medical Officer

  January 8, 2026

   · 

  2 min read
• Press Releases

  Klotho Neurosciences to Present at the Biotech Showcase 2026

  January 8, 2026

   · 

  2 min read
• Press Releases

  Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook

  January 8, 2026

   · 

  11 min read
• Press Releases

  Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease

  January 8, 2026

   · 

  4 min read
• Press Releases

  SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

  January 8, 2026

   · 

  6 min read
• Press Releases

  Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development

  January 8, 2026

   · 

  3 min read